AMP SCZ® Observational Study: PREDICT-DPACC
The Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) is a large international
collaboration to develop algorithms using a set of clinical and cognitive assessments,
multi-modal biomarkers, and clinical endpoints that can be used to predict the trajectori...
Age: 12 - 30 years
Gender: All
The Syn-Sleep Study
In collaboration with approximately 8 centers that specialize in iRBD we will recruit a total of 80 individuals for the study. All subjects will be enrolled into a 2-year longitudinal study where skin biopsies will be performed at 3 sites on each patient at 12-month int...
Age: 18 - 85 years
Gender: All
Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication
The goal of this project is to investigate whether a systematic screening approach enhanced
by an innovative model of communicating information about psychosis and treatment options to
patients and families (ComPsych) can reduce Duration of Untreated Psychosis (DUP)...
Age: 12 - 30 years
Gender: All